CSPC Pharmaceutical Group Ltd HKEX:1093:
INITIATES PHASE III TRIAL OF SYS 6010 WITH ENLONSTOBART IN CHINA
Reuters
CSPC Pharmaceutical Initiates Phase III Trial Of Sys 6010 With Enlonstobart In China
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- HKEX:1093
- Language
- English
CSPC Pharmaceutical Group Ltd HKEX:1093: